An indirect immunofluorescent antibody test (IIFAT) was developed to detect bovine herpesvirus 1 (BHV-1)-specific IgM. All sera were treated with protein-G agarose prior to testing to eliminate the possibility of false-positive results due to IgM-isotype rheumatoid factor (IgM-RF). Specific IgM was first detected 8 days after experimental infection of 3 calves free of maternally derived antibody, with peak responses occurring 2-7 days later. Seroconversion was detected in all 3 calves using a single-dilution enzyme-linked immunosorbent assay. Following reinfection at 30 days postinfection, a low-level IgM response was detected in only 1 calf. Seroconversion was detected in 2 calves. There was no evidence of activation of IgM-RF by infection or reinfection with BHV-1. When 87 acute and convalescent serum pairs collected from 21 outbreaks of respiratory disease were tested, specific IgM was detected in 58 animals (66.6%) from 19 (90.5%) outbreaks. Seroconversion was detected in 44 of these animals (50.6%) from 17 outbreaks (81.0%). The correlations between these 2 assays on a calf and outbreak basis were 79.3% and 90.5%, respectively. Specific IgM was detected in 17/ 20 sera (85.0%) collected from an additional outbreak. No virus was detected by virus isolation or immunofluorescent staining in nasal mucus samples collected at the same time. Detection of specific IgM by IIFAT is a useful technique for the serodiagnosis of BHV-1 infection.
Severe outbreaks of infectious bovine rhinotracheitis (IBR) associated with virulent strains of bovine herpesvirus 1 (BHV-1) have been described in the United Kingdom since the 1970s when subtype 1 strains (BHV-1.1) became increasingly prevalent. 3, 4, 24 Intranasal vaccination with modified live IBR vaccines rapidly induces a protective immune response, 18, 30 so that vaccination in the face of an outbreak is an effective means of limiting associated morbidity and mortality. However, this method of control is dependent upon a rapid diagnosis. Immunofluorescent staining of epithelial cells in nasal mucus samples, as used at the Veterinary Sciences Division Laboratory, Belfast, and elsewhere, is a recognized technique. 5, 24 By comparison, classic serologic techniques based on the detection of seroconversion in paired acute and convalescent sera are of limited value in such cases because of the inherent delay in obtaining a result. However, the use of tests detecting BHV-1-specific IgM, which can be carried out on a single serum sample, offers an alternative means of rapid serologic diagnosis.
IgM-specific indirect and capture enzyme-linked immunosorbent assays (ELISAs) have been described for a number of bovine respiratory viruses, including bovine respiratory syncytial virus, 9, 32 BHV-1, 6 and bo-vine coronavirus. 14 In addition to their use for making a diagnosis with a single acute serum sample, these assays have usually but not always been superior to the detection of seroconversion when used to test sera from field outbreaks of respiratory disease. Immunofluorescent techniques have also been successfully applied to the detection of specific IgM for a number of viruses, including cytomegalovirus, 15 rubellavirus, 7, 16 and porcine reproductive and respiratory syndrome virus. 26 An indirect immunofluorescent antibody test (IIFAT) for BHV-1 IgM was developed and evaluated using sera from both experimental and field infections. IgM-isotype rheumatoid factor (IgM-RF) can generate false-positive results in indirect IgM-specific assays, including IIFATs, for a number of viruses. 29 Various protocols including absorption of IgM-RF with heataggregated IgG 29 or removal of IgG, either by absorption with antiserum to ␥Fc 7,15 or fractionation of serum, 16 have been described to overcome this problem. Pretreatment of sera with protein-G agarose a (PGA) is a simple and effective method of depleting serum IgG, 9 thereby eliminating IgM-RF-induced false-positive results. This protocol was therefore evaluated in the development of the IIFAT for BHV-1-specific IgM. Increased levels of IgM-RF have been reported in association with some but not all viral infections. 28 In at least some cases, this RF may represent anti-idiotype antibody to virus-induced Fc receptors. 23 To determine if IgM-RF is induced by BHV-1, levels were determined following experimental infection and reinfection of calves.
Materials and methods

Animals and sampling
Experimental infections. Three conventionally reared calves (2, 3, 4) , were each inoculated with 20 ml (10 8,43 TCID 50 /ml) of the Colorado strain of BHV-1 grown in fetal bovine lung cells (FBL), receiving 10 ml intratracheally and 5 ml in each nostril. Blood was collected from each calf 8 days before inoculation and 2, 3, 6, 8, 10, 13, 15, 17, 20, 23, 27, 30, 34, 36, 38, 41, 43, 45, 48, 55, 61 , and 68 days postinfection (dpi), and sera were stored at Ϫ20 C for subsequent testing. Each calf was reinfected in the same way at 30 dpi with an inoculum containing 10 6.65 TCID 50 /ml. Parallel serum samples from calves 1, 5, and 6, which had been infected and reinfected with parainfluenza-3 virus (PI3V) at the same interval, served as controls. All calves were seronegative for BHV-1 at initial inoculation and were approximately 5 mo old.
Clinical infections. Field sera from 22 outbreaks of respiratory disease were tested. Samples from outbreaks 1-21 consisted of a stored bank of 87 acute and convalescent serum pairs submitted to the Veterinary Sciences Division Laboratory, Belfast, by private veterinary practitioners and previously tested by single-dilution ELISA for seroconversion. 10 The mean number of animals sampled per outbreak was 4.2, ranging from 2 to 10. The mean intersample interval was 20 days, ranging from 8 to 48 days. The age of the animals involved ranged from 2-mo-old calves to adult dairy cows. Case 22 occurred in a group of 150 6-8-mo-old housed beef cattle. Six animals died of respiratory disease over a 1-mo period, and 1 of these calves was submitted for postmortem examination in week 3 of the outbreak. BHV-1 was detected by immunofluorescent staining of cryostat sections of trachea and lung, and BHV-1 was subsequently isolated from the trachea. One week later, a single serum sample and a nasal swab was collected from each of 20 animals in a single pen from which 3 of the dead calves had originated. At this stage, only 1 of these animals was still showing clinical signs of respiratory disease. Each nasal swab was placed in 5 ml of Hanks' lactalbumin solution (LAH) with 0.035% bovine albumin and processed on the day of collection. Following agitation of each swab/LAH with glass beads, cells were pelleted by centrifugation at 3,000 ϫ g for 30 min at 4 C, and the supernatant was used without further dilution as the inoculum for virus isolation. Each cell pellet was washed once in 0.01 M phosphate-buffered saline (PBS) and resuspended in 300 l of PBS, and a 100-l volume was used to make a cytospin preparation. Each cytospin prep was then fixed in acetone, dried, and tested for the presence of BHV-1 by immunofluorescence using a fluorescein isothiocyanate (FITC)-conjugated anti-BHV-1 monoclonal antibody (MAb). b Virus isolation was performed on coverslip cultures of FBL cells in roller tubes following standard procedures. Cultures were examined daily for 6 days for evidence of virus-induced cytopathic effect (cpe), after which they were fixed and tested for BHV-1 by immunofluorescence.
Growth of BHV-1-infected monolayers for immunofluorescence. Following initial standardization, the following conditions were adopted for the growth of BHV-1-infected monolayers on 12-well multitest slides. c FBL cells suspended in minimal essential medium d supplemented with 10% irradiated fetal calf serum (2.4 ϫ 10 6 cells/ml) were infected with the Colorado strain of BHV-1 at a multiplicity of infection of 0.015, and 70-l volumes were dispensed onto each well. Following incubation for 24 hr at 37 C in 5% CO 2 , slides were washed, fixed in acetone, and stored at Ϫ20 C for future use. This procedure produced semicontinuous monolayers with discrete foci of infection, showing early cpe.
IIFAT protocols. IIFAT for BHV-1 IgM was performed according to standard procedures. 22 To optimize the IIFAT protocol for BHV-1 IgM, sera collected Ϫ8, 15, and 61 dpi from calves 2, 3, and 4 were tested in parallel at a dilution of 1/32 for BHV-1-specific IgG (BHV-1 IgG) and IgM, both with and without prior treatment with PGA. For PGA treatment, sera were diluted 1/32 in PBS containing 40 mg/ml PGA and mixed for 18-24 hr at 4 C. Following clarification at 10,000 ϫ g for 10 min, the supernatant was tested without further dilution. Bound IgM was detected using successive incubations with anti-bovine IgM MAb BM23 a and FITCconjugated rabbit anti-mouse immunoglobulin e (RAMIg-FITC) at respective dilutions of 1/160 and 1/80 in PBS.
BHV-1 IgG was tested for by substituting a pool of MAbs MCA627 (␣IgG 1 ) and MCA626 (␣IgG 2 ), f each at a final dilution of 1/250, in PBS for BM23. Immunofluorescence was read using a 40ϫ oil immersion lens and incident ultraviolet illumination. Positive results were scored from Ϯ to ϩϩϩϩ with increasing intensity. All reagent dilutions were optimized prior to use.
Testing of experimental and field sera. All sera from calves 2, 3, 4, and 5 were screened by IIFAT for BHV-1 IgM following PGA treatment. Positive sera were titrated in 3-fold dilutions and retested to determine end point titers. These sera were also tested by indirect ELISA g for BHV-1 IgG as described previously, 10 with a corrected optical density (COD) value of Ն0.200 indicating a positive result. Sera collected from calves 2, 3, and 4 at 8 days before infection (Ϫ8 dpi) and 23 dpi and at reinfection (30 dpi) and 23 days later were considered to represent acute and convalescent serum pairs and were tested for seroconversion by singledilution ELISA as described previously. 11 An increase in S/ P% value of Ն27.0% between serum pairs indicated a Ն4fold rise in BHV-1 IgG titer and hence seroconversion. Field sera were tested at a single dilution of 1/32 for BHV-1 IgM following PGA treatment. Sera collected from calf 3 at Ϫ8 and 15 dpi were included on each multitest slide as negative and positive controls, respectively.
IgM-RF determination. All sera from calves 2, 3, and 4 (BHV-1) and 1, 5, and 6 (P13V) were tested for IgM-RF by ELISA at a serum dilution of 1/100, as previously described. 8
Results
IIFAT protocols. In the absence of PGA treatment, BHV-1 IgM was detected at 15 dpi from calves 2, 3, and 4 (intensity ϩϩ to ϩϩ/ϩ). In addition, calves 3 and 4 were weakly positive (Ϯ) at 61 dpi (Table 1) . Following PGA treatment, all 3 calves remained pos- itive at 15 dpi, with an increased intensity of fluorescence (ϩϩϩϩ) but were negative at 61 dpi. BHV-1 IgG was detected at 15 and 61 dpi without PGA treatment. Following PGA treatment, all sera were negative for BHV-1 IgG.
Testing of experimental sera. No BHV-1 IgG or IgM responses were detected in the control calf (calf 5). Calves 2, 3, and 4 first tested positive for BHV-1 IgG at 10 dpi, thereafter showing a gradual increase in COD value to 68 dpi ( Fig. 1) . BHV-1 IgM responses were first detected at 8 dpi in calves 2, 3, and 4. Peak responses were detected at 10-15 dpi, with titers ranging from 1/288 to 1/2,592. Thereafter, titers decreased, becoming negative at 38-48 dpi. No increase in titer was observed following reinfection in calves 3 and 4. In calf 2, an increase in titer from 1/32 to 1/96 was detected between 4 and 6 days postreinfection, after which titers decreased again (Fig. 1) . Following infection, seroconversion was detected in calves 2, 3, and 4, with increases in S/P% ranging from 44.05% to 49.98%. After reinfection, seroconversion was again detected in calves 3 and 4, with increases in S/P% values of 41.29% and 34.24%, respectively, but not in calf 2, where an increase of only 12.92% was detected.
Testing of acute and convalescent serum pairs from field outbreaks. The results of testing acute and convalescent serum pairs from field outbreaks of respiratory disease for BHV-1 IgM are summarized in Tables  2 and 3 . Specific IgM was detected in 89/174 (51.1%) serum samples from 58/87 (66.6%) animals. In 31 (35.6%) animals, both acute and convalescent serum samples tested positive. In 9 others (10.3%), only the acute serum sample tested positive, whereas in the remaining 18 animals (20.7%), only the convalescent se- * A change from seronegative to seropositive, or a Ն4-fold increase in specific titer, as measured by single-dilution ELISA. rum sample tested positive. One or more animals from 19 outbreaks (90.5%) tested positive for BHV-1 IgM ( Table 3) .
When these serum pairs were previously tested by single-dilution ELISA, seroconversion to BHV-1 was detected in 44 animals from 17 outbreaks. BHV-1 IgM was detected in an additional 16 animals that did not seroconvert. Seroconversion was detected in 2 animals negative for BHV-1 IgM. One or more animals from 2 outbreaks in which seroconversion was not detected were positive for BHV-1 IgM. The correlation between seroconversion and BHV-1 IgM results on an animal and herd basis were 79.3% and 90.5%, respectively.
Testing of serum and swabs from outbreak 22. Nasal swabs from all 20 animals in case 22 tested negative for BHV-1 by both immunofluorescent staining of cytospin preparations and virus isolation. However, BHV-1 IgM was detected in the serum of 17 of these animals, with the intensity of staining ranging from ϩ to ϩϩϩϩ.
IgM-RF determination. The mean IgM-RF COD values of the 2 groups of calves at each time point from Ϫ8 dpi to 68 dpi are shown in Fig. 2 . There was no evidence of induction of IgM-RF following infection or reinfection with either virus, and mean COD values were not significantly different between the 2 groups at any point.
Discussion
An IIFAT incorporating PGA treatment of serum was successfully developed to detect BHV-1-specific IgM. Consistent with previous findings, 9 PGA treatment of sera resulted in depletion of serum IgG, removing the possibility of IgM-RF-induced false-positive results while increasing the intensity of specific staining ( Table 1 ). The observed patterns of IgM responses to infection and reinfection were similar to those previously detected by IgM capture ELISA 20, 21 and plaque reduction neutralization assay on fractionated serum. 12 The transient nature of the IgM response to initial infection confirmed the validity of interpreting a positive BHV-1 IgM result as being indicative of recent infection. The minimal or absent IgM response to reinfection indicated that a positive result is most likely associated with primary infection rather than reinfection. However, low titer IgM responses have also been described following reactivation of latent infection. 13 Testing of field sera confirmed the serodiagnostic potential of BHV-1 IgM, as in previous reports. 6, 31 In this study, the detection of BHV-1 IgM by IIFAT was superior to testing by single-dilution ELISA for seroconversion (i.e., a change in status from seronegative to seropositive, or Ն4-fold increase in specific titer). This is in contrast to a previous report, 6 where, using a capture ELISA, BHV-1 IgM was detected less commonly than seroconversion on both an individual animal and herd basis. This discrepancy may reflect differences in test methodologies or sampling protocols. Although there was close overall agreement between the 2 assays for each calf (79.3%, Table 3 ), BHV-1 IgM was detected in 16 animals that did not seroconvert. Analysis of the IgG S/P% values of the acute and convalescent sera from these animals and their ages (data not shown) suggested a number of possible explanations. First, the IgM response to BHV-1 is less susceptible to suppression in the presence of maternally derived antibody than is the specific IgG response. 2 Second, if the acute serum sample is collected too late in the course of infection, the subsequent increase in BHV-1 IgG levels may be insufficient to demonstrate a 4-fold rise in titer. Third, individual animals may have detectable BHV-1 IgM in their convalescent serum samples without seroconversion because infection actually occurred in the intersample interval.
The results from outbreak 22 indicate that the detection of BHV-1 IgM is superior to immunofluorescent staining of cells from nasal swabs in at least some cases. Following primary BHV-1 respiratory infection, virus can be isolated for 8-10 days, 2,4,6 whereas specific IgM, as shown here, is detectable by IIFAT for longer periods. The superiority of the BHV-1 IgM assay in this outbreak is likely to be a reflection of the longer period for which specific IgM is detectable, given that nasal swabs and sera were not collected until week 4 of the outbreak in this herd, when many animals may have ceased shedding virus.
Receptors for the Fc domain (FcR) of IgG have been demonstrated on the surfaces of cells following infection with a number of alphaherpesviruses of humans, including herpes simplex virus (HSV) 1, 17 HSV-2, 25 varicella-zoster virus, 19 and cytomegalovirus. 27 These viral FcRs may be responsible for induction of RFs, which may represent anti-idiotype antibodies to these receptors. 23 However, although the expression of FcR associated with equine herpesvirus 1 and bovine herpesvirus 2 has been demonstrated, this activity was not found with BHV-1.1. 1 The absence of an IgM-RF response in the immediate period following infection and reinfection described in the present study is consistent with this finding.
Testing for BHV-1 IgM by IIFAT is a viable alternative to testing acute and convalescent serum samples for seroconversion. Preliminary results indicate that this test may also be a useful adjunct to immunofluoresent staining of nasal mucus samples for BHV-1. However, a larger study (currently underway) is necessary to fully compare the diagnostic potential of these 2 tests.
